Lenox Wealth Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Lenox Wealth Advisors’s Portfolio SGYP Stock Details SGYP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,151	Closed	–	–	823
2021 Q1	$0	Hold	1,151	–	–	﹤0.01%	780
2020 Q4	$0	Buy	+1,151	New	–	﹤0.01%	702
2020 Q3	–	Sell	-1,151	Closed	–	–	674
2020 Q2	$0	Hold	1,151	–	–	﹤0.01%	849
2020 Q1	$0	Hold	1,151	–	–	﹤0.01%	984
2019 Q4	$0	Buy	+1,151	New	–	﹤0.01%	852

Lenox Wealth Advisors's SGYP Position: Q2 2021 in Review

Lenox Wealth Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q2 2021, closing a stake of 1,151 shares.

Lenox Wealth Advisors first reported a position in SGYP in Q4 2019 and held it in 5 quarters. The position peaked at $0 in Q1 2021. 2 funds tracked by Wall St. Rank hold SGYP as of Q2 2021.

Lenox Wealth Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q2 2021 after selling out during the quarter.
Lenox Wealth Advisors sold 1,151 Synergy Pharmaceuticals, Inc Common Stock shares in Q2 2021.
Lenox Wealth Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2019 and held it in 5 quarters.
Lenox Wealth Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $0 in Q1 2021.
2 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q2 2021.

Based on Lenox Wealth Advisors's 13F filing for Q2 2021, filed 8 Jul 2021.